drugset / Trial / NCT05208398
Apixaban in Patients With Left Ventricular Thrombus
RandomizedParallel-groupSingle-blindTreatment
Summary
Open label randomized controlled clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in treating left ventricular thrombus in patients with acute or recent myocardial infarction (MI).
Timeline
- Start
- 2018-02-18
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apixaban | Small molecule | 5 mg | Oral |
| Comparator | Warfarin | Small molecule | — | Oral |